(1S,9S)-9-{[(2R)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]amino}-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid
![(1S,9S)-9-{[(2R)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]amino}-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid Structure](https://image.chemsrc.com/caspic/453/106928-09-0.png)
(1S,9S)-9-{[(2R)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]amino}-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid structure
|
Common Name | (1S,9S)-9-{[(2R)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]amino}-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid | ||
|---|---|---|---|---|
| CAS Number | 106928-09-0 | Molecular Weight | 417.499 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 598.1±60.0 °C at 760 mmHg | |
| Molecular Formula | C22H31N3O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 315.5±32.9 °C | |
|
Cilazapril stability in the presence of hydrochlorothiazide in model mixtures and fixed dose combination.
Acta Pol. Pharm. 70(6) , 1079-85, (2013) The presented study aimed at the evaluation of hydrochlorothiazide influence on cilazapril stability in model mixture and fixed dose tablet formulation. The degradation of cilazapril in the presence of hydrochlorothiazide took place according to autocatalytic... |
|
|
Common medications among dental outpatients: considerations in general dental practice.
N. Z. Dent. J. 108(4) , 140-7, (2012) To provide information about the most common medications listed as being taken by dental patients presenting to an outpatient setting at a tertiary institution and to establish a list of the most common medications for review for the general dental practition... |
|
|
Ultra-thin-layer chromatography mass spectrometry and thin-layer chromatography mass spectrometry of single peptides of angiotensin-converting enzyme inhibitors.
J. Chromatogr. A. 1218(20) , 3089-94, (2011) The separation of structurally related angiotensin-converting enzyme (ACE) inhibitors lisinopril, cilazapril, ramipril and quinapril and their corresponding active diacid forms (prilates) by conventional TLC silica gel 60 plates was contrasted with that affor... |
|
|
[Successful treatment of polymedicamentous poisoning with metoprolol, diltiazem and cilazapril].
Vojnosanit. Pregl. 66(11) , 904-8, (2009) Poisoning caused by drugs with cardiodepressive effects is an urgent condition in medicine which is associated with high mortality rate regardless of modern therapeutic methods. Accidental or intentional poisoning whit these drugs produces heart activity depr... |
|
|
Rapid and simple stability indicating HPLC method for the determination of cilazapril in pure substance and pharmaceutical formulation in comparison with classic and derivative spectrophotometric methods.
Acta Pol. Pharm. 69(2) , 193-201, (2012) The present study describes development and subsequent validation of high performance liquid chromatographic method (HPLC) in comparison with spectrophotometric methods (classic, first, second and third order derivative) for determination of pure cilazapril i... |
|
|
How controlling of hypertension might matter.
Circ. J. 73(12) , 2208-9, (2009)
|
|
|
IgA nephropathy: a disease in search of a large-scale clinical trial to reliably inform practice.
Am. J. Kidney Dis. 53(1) , 5-8, (2009)
|
|
|
High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease.
Nephrol. Dial. Transplant. 24(2) , 689-90, (2009)
|
|
|
Spironolactone attenuates oxidative stress in patients with chronic kidney disease.
Hypertension 52(5) , e132-3; author reply e134, (2008)
|
|
|
The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.
Lab. Invest. 94(8) , 839-50, (2014) Peritoneal fibrosis is a complication of patients with long-term continuous ambulatory peritoneal dialysis (CAPD). Reports have indicated that angiotensin (Ang) II may correlate with the development of peritoneal fibrosis. However, it is unknown whether aldos... |